NDA 091688 describes TROSPIUM CHLORIDE, which is a drug marketed by
Actavis Labs Fl Inc,
Amta,
Granules,
Padagis Us,
Upsher Smith Labs,
Apotex,
Glenmark Pharms Ltd,
Heritage Pharms Inc,
Invagen Pharms, and
Zameer Pharms, and is included in eleven NDAs. It is available from
eighteen suppliers. Additional details are available on the
TROSPIUM CHLORIDE profile page.
The generic ingredient in TROSPIUM CHLORIDE is
trospium chloride. There are sixteen
drug master file entries for this compound. Eighteen
suppliers are listed for this compound. Additional details are available on the
trospium chloride profile page.